Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 17/Signature 1

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Svetlana up on 2024-7-23

Curated date: 2024/04/24

Curator: Scholastica

Revision editor(s): Scholastica

Source: Fig. 4B

Description: Differentially abundant taxa in breast cancer patients 12 months after Chemotherapy with neurotoxicity compared to those without neurotoxicity

Abundance in Group 1: increased abundance in With neurotoxicity (Post-Chemo)

NCBI	Quality Control	Links
Bacteroides uniformis
Flavonifractor plautii
Anaerotruncus colihominis
[Clostridium] symbiosum
Eggerthella lenta
Thomasclavelia spiroformis
Enterocloster citroniae
Bacteroides thetaiotaomicron
Ruthenibacterium lactatiformans
Thomasclavelia ramosa
Dielma fastidiosa
Intestinimonas butyriciproducens
Enterocloster aldenensis
Anaerostipes hadrus
Enterocloster bolteae
Anaeromassilibacillus sp. An250
Enterocloster asparagiformis
Enterococcus durans

Revision editor(s): Scholastica